Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Torben Steiniche"'
Autor:
Frede Donskov, Cathy Anne Pinto, Raluca Predoiu, Claire Fox, Jeanette Baehr Georgsen, Katrine Skaarup, Mehmet Burcu, Rodolfo Perini, Torben Steiniche
Publikováno v:
Donskov, F, Pinto, C A, Predoiu, R, Fox, C, Georgsen, J B, Skaarup, K, Burcu, M, Perini, R & Steiniche, T 2022, ' Molecular analysis and favorable clinical outcomes in real-world patients with metastatic renal cell carcinoma ', Acta Oncologica, vol. 61, no. 10, pp. 1268-1277 . https://doi.org/10.1080/0284186X.2022.2119100
BACKGROUND: Prior biomarker studies have mainly been restricted to advanced RCC patients treated in clinical trials or have had limited integration of immunotherapy features such as programmed death ligand (PD-L)-1 with gene expression signatures int
Autor:
Jeanette Bæhr Georgsen, Jesper Grau Eriksen, Stine Rosenkilde Larsen, Deepti Aurora-Garg, Thao Vo, Jens Overgaard, J. Lilja-Fischer, Jonathan D. Cheng, Torben Steiniche, Michael Busch-Sørensen
Publikováno v:
Lilja-Fischer, J K, Eriksen, J G, Georgsen, J B, Vo, T T, Larsen, S R, Cheng, J, Busch-Sørensen, M, Aurora-Garg, D, Steiniche, T & Overgaard, J 2020, ' Prognostic impact of PD-L1 in oropharyngeal cancer after primary curative radiotherapy and relation to HPV and tobacco smoking ', Acta Oncologica, vol. 59, no. 6, pp. 666-672 . https://doi.org/10.1080/0284186X.2020.1729407
Background: Incidence of oropharyngeal squamous cell carcinoma (OPSCC) is rising rapidly in many western countries due to Human papillomavirus (HPV) and tobacco smoking, with a considerable overlap. Immunotherapy directed at the PD1/PD-L1 axis have s
Autor:
Ole Lajord Munk, Tobias Wang, Steen Jakobsen, Torben Steiniche, Michael R. Horsman, Morten Busk, Marianne Skals, Jens Overgaard
Publikováno v:
Busk, M, Munk, O L, Jakobsen, S, Wang, T, Skals, M, Steiniche, T, Horsman, M R & Overgaard, J 2010, ' Assessing hypoxia in animal tumor models based on pharmocokinetic analysis of dynamic FAZA PET ', Acta Oncologica, vol. 49, no. 7, pp. 922-33 . https://doi.org/10.3109/0284186X.2010.503970
Udgivelsesdato: 2010-Oct Abstract Positron emission tomography (PET) allows non-invasive detection and mapping of tumor hypoxia. However, slow tracer kinetics and low resolution, results in limited tumor-to-normal tissue contrast and the risk of miss